-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Karyopharm Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
- Karyopharm Therapeutics Inc. Return On Equity for the quarter ending September 30, 2024 was 58.6 %, a 75.5% decline year-over-year.
- Karyopharm Therapeutics Inc. annual Return On Equity for 2023 was 162 %, a 12.6% decline from 2022.
- Karyopharm Therapeutics Inc. annual Return On Equity for 2022 was 186 %, a 22.8% increase from 2021.
- Karyopharm Therapeutics Inc. annual Return On Equity for 2021 was 151 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)